Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sterna Biologicals
AddedMar 22, 2024
UpdatedJun 18, 2026
Sterna Biologicals

Sterna Biologicals

Marburg-based company developing solutions for dysregulated type-2 immunity, targeting chronic inflammatory conditions.

HQ
Marburg, Hesse, DE
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Sterna Biologicals, founded in Marburg, Germany, focuses on developing innovative therapies for dysregulated type-2 immunity, which is linked to chronic inflammatory conditions such as asthma. The company's core mission is to improve the quality of life for individuals suffering from these conditions by offering targeted biological treatments. Their vision is to lead in the field of immunological research and provide effective solutions for chronic inflammation.

Notable figures associated with Sterna Biologicals include experts in immunology and chronic inflammatory diseases. The company has attracted significant investment from leading biotech investors, enabling it to advance its research and development efforts. Key achievements include the successful development of promising therapeutic candidates and securing patents for their unique treatment approaches. Sterna Biologicals has made a substantial impact on the biotech industry by addressing unmet medical needs in chronic inflammatory diseases.

Sterna Biologicals - Similar Companies

HI-Bio logo

HI-Bio

hibio.com

Therini Bio logo

Therini Bio

therinibio.com

Q32 Bio logo

Q32 Bio

q32bio.com

Transcera logo

Transcera

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

Cleveland BioLabs logo

Cleveland BioLabs

Therabiol logo

Therabiol

Aristea Therapeutics logo

Aristea Therapeutics

Granata Bio logo

Granata Bio

granata.bio

DermBiont logo

DermBiont

dermbiont.com

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Equillium logo

Equillium

equilliumbio.com

HCW Biologics logo

HCW Biologics

hcwbiologics.com

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Evommune logo

Evommune

evommune.com

Sterna Biologicals - Quick Facts

Who are Sterna Biologicals' competitors?

Companies similar to Sterna Biologicals include HI-Bio, Therini Bio, Q32 Bio and Transcera.

When was Sterna Biologicals founded?

Sterna Biologicals was founded in 2006.

Where is Sterna Biologicals' headquarters located?

Sterna Biologicals' headquarters is located in Marburg, Hesse, DE.

How much has Sterna Biologicals raised to-date?

As of Aug 22, 2022, Sterna Biologicals has raised a total of $22M (USD).

How many employees does Sterna Biologicals have?

Sterna Biologicals has 17 employees as of Feb 24, 2024.

Sterna Biologicals - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Asthma
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified